Picodya Technologies

In Vitro Diagnostics (IVD) Platform

Health Tech & Life Sciences
Private

Company Overview

Snapshot

Founded in February 2018 by Eli Ben Simon and Tzvika Barkai, Picodya Technologies operates with 11–50 employees. The company has raised a total of $51.4M across 10 funding rounds. In January 2024, Picodya Technologies secured a grant, highlighting ongoing support for its diagnostic innovations.

Business overview

Picodya Technologies is a Health Tech & Life Sciences company focused on In Vitro Diagnostics (IVD). The company develops the B-Matrix, a microfluidic lab-on-a-chip platform that enables simultaneous hybrid testing for both molecular and immunoassays. This system supports multiplexed syndromic panels for various sample types, aiming to reduce costs through multi-use consumables and offer less invasive patient experiences. Picodya's technology is designed for diverse clinical settings, including hospitals, urgent care, physician offices, and emerging settings like airports, pharmacies, and homes, operating within the Digital Medical Diagnostics and Diagnostics Devices sectors.

Strategic signal

In January 2024, Picodya Technologies secured a grant, indicating continued external validation and financial support for its diagnostic platform. This development signals to investors a sustained commitment to advancing its technology and expanding its market reach, particularly in the context of broader initiatives like pandemic preparedness, as highlighted by its system's adoption through an NIH pandemic initiative.

Company Intelligence Q&A

What is Picodya Technologies' primary product?
Picodya Technologies' primary product is the B-Matrix, a microfluidic lab-on-a-chip platform designed for in vitro diagnostics, supporting both molecular and immunoassays.
When was Picodya Technologies founded?
Picodya Technologies was founded in February 2018 by Eli Ben Simon and Tzvika Barkai.
What was a significant recent development for Picodya Technologies?
In January 2024, Picodya Technologies secured a grant, demonstrating ongoing support for its diagnostic innovations.
How much capital has Picodya Technologies raised in total?
Picodya Technologies has raised a total of $51.4M across 10 funding rounds.

External links